Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain Essay

Exclusively available on Available only on IvyPanda® Written by Human No AI

There are four major dopamine pathways. The mesolimbic pathway is responsible for the functions usually associated with dopamine, which are reward and pleasure. The pathway originates in the ventral tegmental area, a dopamine-rich nucleus in the midbrain from where action potentials are emitted to the nucleus accumbens (Guy-Evans, 2022). The mesocortical pathway also originates from the ventral tegmental area but moves to the prefrontal cortex. A disturbance in this process may cause various dysfunctions including issues with working memory, cognition, and decision-making. The dopamine is relocated from the substantia nigra to the caudate and putamen through the nigrostriatal pathway (Guy-Evans, 2022). Reduction in dopamine levels within this pathway may result in poorer motor planning. The tuberoinfundibular pathway releases dopamine in order to reduce prolactin release. It begins in the arcuate and periventricular nuclei and moves to the infundibular region within the hypothalamus.

Within the mesolimbic pathway, every antipsychotic drug can reduce dopaminergic levels. A decrease in dopamine levels in the nucleus accumbens can cause fewer cravings for dopamine-producing activities (Guy-Evans, 2022). On the other hand, overstimulation with an increase in dopamine dramatically expands this craving. Though the use of antipsychotics or other medication on the mesocortical pathway may increase or decrease motor capabilities, it has the potential for negative side effects on the mesolimbic pathway. Antipsychotics that limit dopamine in the nigrostriatal pathway may cause motor control impairment. A disbalance caused by D2 antagonists, which may be first-generation antipsychotics, can lead to symptoms such as contractions, spasms, parkinsonism, tremors, and more (Guy-Evans, 2022). In the tuberoinfundibular pathway, antipsychotics may contribute to higher prolactin levels and can lead to hyperprolactinemia.

Reference

Guy-Evans, O. (2022). . Simply Psychology. Web.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2024, January 21). Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain. https://ivypanda.com/essays/dopamine-pathways-the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/

Work Cited

"Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain." IvyPanda, 21 Jan. 2024, ivypanda.com/essays/dopamine-pathways-the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/.

References

IvyPanda. (2024) 'Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain'. 21 January.

References

IvyPanda. 2024. "Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain." January 21, 2024. https://ivypanda.com/essays/dopamine-pathways-the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/.

1. IvyPanda. "Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain." January 21, 2024. https://ivypanda.com/essays/dopamine-pathways-the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/.


Bibliography


IvyPanda. "Dopamine Pathways: The Role of Dopamine as a Neurotransmitter in the Human Brain." January 21, 2024. https://ivypanda.com/essays/dopamine-pathways-the-role-of-dopamine-as-a-neurotransmitter-in-the-human-brain/.

If, for any reason, you believe that this content should not be published on our website, you can request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
1 / 1